Postoperative risk stratification in oral squamous cell carcinoma.


Journal

The British journal of oral & maxillofacial surgery
ISSN: 1532-1940
Titre abrégé: Br J Oral Maxillofac Surg
Pays: Scotland
ID NLM: 8405235

Informations de publication

Date de publication:
05 2020
Historique:
received: 14 09 2019
accepted: 24 02 2020
pubmed: 31 3 2020
medline: 21 10 2020
entrez: 31 3 2020
Statut: ppublish

Résumé

Postoperative prognostic stratification using the Union for International Cancer Control (UICC) TNM 8th edition staging rules (UICC 8) may identify additional groups of patients who could benefit from adjuvant radiotherapy. Currently, selection for such treatment is not based on all known prognostic factors, and their relative importance may vary depending on the overall risk category. The objective of this study therefore was to evaluate these possibilities. We retrospectively studied 644 patients who had surgery with curative intent for oral squamous cell carcinoma (OSCC) between March 2006 and February 2017. The outcomes of interest were disease-specific survival (DSS) and locoregional recurrence (LRR). Patients were re-staged according to the UICC 8 staging rules. Putative clinical and pathological prognostic variables were evaluated and hazard ratios estimated. Regression analysis was done to identify independent prognostic factors, and iterative analyses identified clinically-relevant risk categories with a minimum of residual prognostic variables. The significance of recognised pathological prognostic factors differed according to the overall risk category. An intermediate risk group comprising patients with pN1 disease as well those with pT3 disease solely on the basis of a depth of invasion (DOI) of more than 10 mm, was identified. A trial to evaluate the benefit or otherwise of adjuvant radiotherapy in this group is now required. Individual prognostic risk factors should be considered within the context of the overall risk category in patients with OSCC.

Identifiants

pubmed: 32222310
pii: S0266-4356(20)30098-X
doi: 10.1016/j.bjoms.2020.02.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-468

Informations de copyright

Copyright © 2020 The British Association of Oral and Maxillofacial Surgeons. All rights reserved.

Auteurs

J D McMahon (JD)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: jeremymcmahon@nhs.net.

R Pitts (R)

Medical and Life Sciences Schools, University of Dundee. Electronic address: ruaripitts@hotmail.com.

J Isbister (J)

University of Glasgow Medical School. Electronic address: jisbister@googlemail.com.

B Aslam-Pervez (B)

QueenElizabeth University Hospital, Glasgow. Electronic address: Bilal.aslam-pervez@nhs.net.

A James (A)

Beatson Oncology Centre, NHS Greater Glasgow and Clyde Health Board. Electronic address: allan.james@ggc.scot.nhs.uk.

D McLellan (D)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: Douglas.McLellan@ggc.scot.nhs.uk.

S Wright (S)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: sylviawright@nhs.net.

C J Wales (CJ)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: Craig.Wales@nhs.net.

J McCaul (J)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: Jim.mccaul@mac.com.

E Thomson (E)

NHS Forth Valley Health Board. Electronic address: ewenthomoson@nhs.net.

M J Ansell (MJ)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: mjansell@doctors.org.uk.

W S Hislop (WS)

NHS Ayrshire and Arran Crosshouse Hospital. Electronic address: Stuart.Hislop@aapct.scot.nhs.uk.

C MacIver (C)

Maxillofacial / Head and Neck Unit, Mafraq Hospital. Electronic address: cmaciver@seha.ae.

J C Devine (JC)

Maxillofacial / Head and Neck Unit, Mafraq Hospital. Electronic address: John.devine20@btinternet.com.

E Carson (E)

Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board. Electronic address: eva.carson@ggc.scot.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH